2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Tuesday, June 5, 2018

5:30pm-5:42pm: Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis

K. Phonphok, T. Duong, S. Panombualert, S. Bunnapradist.

Concurrent Session: Kidney Donor Selection / Management Issues - 2 • Room 6E

5:30pm-5:42pm: Post-Transplant Outcomes under the New HCC Exception Policy

T. Ishaque, A. Massie, C. Haugen, D. Segev.

Concurrent Session: Liver: Hepatocellular Carcinoma and Other Malignancies • Room 6C

5:30pm-5:42pm: TORC1 Inhibition Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

B. Al Dulaijan, S. Eskandari, J. Karnyski, J. Assaker, S. Cai, A. Mansouri, M. Mohamed, J. Azzi.

Concurrent Session: New Approaches to Target Regulatory T Cells • Room 618/619/620

5:30pm-5:42pm: Two Trajectories of Post-DSA eGFR after Kidney Transplant

J. Beaumont,¹ K. Briley,² A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² L. Rebellato,² M. Everly.¹

Concurrent Session: Kidney Complications: Antibody & Late Outcomes • Room 4B

5:30pm-5:42pm: Urinary C5b-9 is an Independent Predictor of Graft Failure in Renal Transplant Recipients

R. Lammerts, M. Eisenga, M. Alyami, M. Seelen, M. Daha, J. van den Born, S. Bakker, S. Berger, On behalf of the COMBAT Comsortium.

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes: Clinical • Room 602/603/604

5:42pm-5:54pm: All DQ DSA May Not Be Equal: Comparing Outcomes between De Novo DQ DSA Specificities

M. Everly,¹ K. Briley,² A. Nguyen,¹ V. Jucaud,¹ A. Maldonado,³ C. Haisch,² P. Bolin,² S. Kendrick,⁴ H. Jones,⁴ K. McLawhorn,⁴ D. Leeser,² L. Rebellato.²

Concurrent Session: Kidney Complications: Antibody & Late Outcomes • Room 4B

5:42pm-5:54pm: Antiviral Therapy for Donor-Derived Hepatitis C Virus Infection after Solid Organ Transplantation

A. Kwong,¹ A. Wall,² M. Melcher,² U. Wang,³ A. Ahmed,¹ K. Khush,³ A. Subramanian,³ J. Tan,³ P. Kwo.¹

Concurrent Session: New Frontiers in HIV and Hepatitis • Room 4C-3

5:42pm-5:54pm: Curative Correction of FAH Deficiency by Chimeric Stem Cells Transplantation

D. Joo,^1,2 E. Nelson,¹ Y. Zhang,¹ B. Amiot,¹ S. Ho,³ C. Lancto,⁴ D. Carlson,⁴ L. Queiroz,⁵ S. Nyberg.¹

Concurrent Session: Cellular Therapies and to Promote Tolerance • Room 606/607

5:42pm-5:54pm: Development of Post-Transplant DSA Following Immunosuppression Minimization/Withdrawal in Liver Transplant Recipients

V. Jucaud,¹ A. Shaked,² M. DesMarais,³ P. Sayre,³ M. Everly.¹

Concurrent Session: Tolerance: Clinical Studies • Room 210

5:42pm-5:54pm: DSA with TCMR Identifies High Risk Renal Transplant Recipients That Can Be Predicted by Proinflammatory Transitional B Cells

D. Chittka, A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes: Clinical • Room 602/603/604